Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

Published studies on the risk of radiation-induced second primary malignancy (SPM) after radioiodine treatment (RAI) of differentiated thyroid cancer (DTC) refer mainly to patients treated as middle-aged or older adults and are not easily generalizable to those treated at a younger age. Here we revi...

Full description

Bibliographic Details
Main Authors: Christoph Reiners, Rita Schneider, Tamara Platonova, Mikhail Fridman, Uwe Malzahn, Uwe Mäder, Alexis Vrachimis, Tatiana Bogdanova, Jolanta Krajewska, Rossella Elisei, Fernanda Vaisman, Jasna Mihailovic, Gracinda Costa, Valentina Drozd
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Endocrinology
Subjects:
differentiated thyroid carcinoma
radioiodine therapy
iodine-131
long-term complications
young females
childhood and adolescence
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2020.00381/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2020.00381/full

Similar Items